HSE Health Protection Surveillance Centre. Sample Root Cause Analysis Tool of Hospital-acquired Clostridium difficile Infection



Similar documents
General information and infection prevention and control precautions to prepare for and manage norovirus in care homes

C. difficile. Answers to frequently asked questions about. at the Jewish General Hospital. SIR MORTIMER B. DAVIS JEWISH GENERAL HOSPITAL

Management of Norovirus Infection Outbreaks in Hospitals and Nursing Homes Noroviruses are a group of viruses that cause acute gastroenteritis in

Prevention and control of infection in care homes. Summary for staff

Clostridium difficile Infection (CDI) Gail Bennett, RN, MSN, CIC

Massachusetts Department of Developmental Services MRSA, VRE, and C. Diff Management Protocol

C. difficile Infections

Prepared by: Dr Peder Bo Nielsen, Director of infection Prevention & Control

Clostridium difficile infection: How to deal with the problem

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

Hand Hygiene and Infection Control

Surveillance, Diagnosis and Management of Clostridium difficile Infection in Ireland. National Clinical Guideline No. 3

METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) COMMUNITY ACQUIRED vs. HEALTHCARE ASSOCIATED

Lab ID Events MRSA Bloodstream Infection and C. difficile

Baseline assessment checklist for the AICG recommendations

ECDC INTERIM GUIDANCE

Road Map to a Comprehensive Clostridium difficile. Infection (CDI) Prevention Program

Clostridium difficile infection in Europe A CDI Europe Report

Appendix B: Provincial Case Definitions for Reportable Diseases

British Columbia Clostridium difficile Infection (CDI) Toolkit and Clinical Management Algorithm

Solid Organ Transplantation

Norovirus Outbreak Among Residents of an Assisted Living Facility, Houston County, Alabama 2010 (AL1003NRV 35a)

Inhibit terminal acid secretion from parietal cells by blocking H + /K + - ATPase pump

Clostridium difficile (C. difficile)

fåñéåíáçå=mêéîéåíáçå=~åç=`çåíêçäw= fãéêçîáåö=íüêçìöü=ié~êåáåö=

Cleaning Guidelines for Care Homes. Includes cleaning standards for the general environment and equipment

Methicillin resistant staphylococcus aureus (MRSA)

VARICELLA ZOSTER (VZ) VIRUS, CHICKENPOX & SHINGLES GUIDANCE

Guidelines for the management of norovirus outbreaks in acute and community health and social care settings

Recommendations for the Prevention and Control of Influenza in Nursing Homes Virginia Department of Health

Policy on precautions to be observed when caring for patients colonised or infected with Extended Spectrum Beta Lactamase producing organisms (ESBL

4.06. Infection Prevention and Control at Long-term-care Homes. Chapter 4 Section. Background. Follow-up on VFM Section 3.06, 2009 Annual Report

Bed Cleaning Procedure

EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY. Methicillin-resistant Staph aureus: Management in the Outpatient Setting

C-Difficile Infection Control and Prevention Strategies

VUMC Guidelines for Management of Indwelling Urinary Catheters. UC Access/ Maintenance

Ebola virus disease. Filoviridae: enveloped RNA viruses

Healthcare Support Worker Induction Book

MRSA, Hand Hygiene and Contact Precautions

A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page

Standard Precautions. These guidelines must be implemented b y all healthcare workers. Standard Precautions version th April

Guidelines for the management of norovirus outbreaks in acute and community health and social care settings

Develop an understanding of the differential diagnosis of pseudomembranous colitis

TRUST BOARD IN PUBLIC Date: 31 st January Agenda Item: 2.3

PROCEDURE FOR CATHETER AFTERCARE

CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08

Infection Prevention and Control Program Risk Assessment 2011

Infection Control Program Risk Assessment 2008

NOROVIRUS INCIDENTS & OUTBREAKS IN NURSING & RESIDENTIAL HOMES

Surgical site (operation wound) infection

Illinois Long Term Care Facilities and Assisted Living Facilities

Aseptic Technique Policy and Procedure

Inspecting Informing Improving. Hygiene code inspection report: South Western Ambulance Service NHS Trust

Hospital Preparation and Team Development

Requirements for Prevention and Detection of Influenza Outbreaks Aide Memoire Season

RQIA Infection Prevention/Hygiene Announced inspection

Ambulance Service. Patient Care. and. Transportation Standards

Data Collection Tool Sponsored by the Hand Hygiene Targeted Solutions Tool

Travel and transport risk assessment: Recommendations for public health authorities and transport sector

Best Practice Guidelines for the Prevention & Management of Clostridium difficile Infection In Prehospital, Acute & Continuing Care

Policy for Screening Patients for MRSA Colonisation

CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

Everyone counts Ambitions for GCCG for 7 key outcome measures

CLEAN UP FOR VOMITING & DIARRHEAL EVENT IN RETAIL FOOD FACILITIES

SECTION 12.1 URINARY CATHETERS

Risk Assessment for all Healthcare workers. Gayle Lohr & Joanne Baines Leaders, Infection Prevention & Control

INFECTION CONTROL PRECAUTIONS

Objective. Suggested Reading: WHO Aide-Memoire: Hand Hygiene How to Hand Rub / How to Hand Wash Poster. Hand out/materials See activities

CLOSTRIDIUM DIFFICILE INFECTION INFECTION PREVENTION AND CONTROL GUIDANCE FOR MANAGEMENT IN ACUTE CARE SETTINGS

Objectives. Long Term Acute Care Hospital and Skilled Nursing Facility Infection Prevention & Control Regulations & Survey Preparation

Linen and Laundry Guidance. Infection Control

Guidelines for Hand Foot and Mouth Disease HFMD

Moving to a hospital or skilled nursing facility

Interim Ebola Protocol: Inmate Screening and Management

Case Study: Chesterfield Royal Hospital NHS Foundation Trust The Importance of Good Governance

Infection Prevention and Control Policy

What Is. Norovirus? Learning how to control the spread of norovirus. Web Sites

INFECTION CONTROL POLICY

Safety FIRST: Infection Prevention Tips

INFECTION CONTROL POLICY MANUAL

WASH Package for Ebola Care and Treatment Centres/Units. Guidance Note

Analysis of Klebsiella Outbreak in Neonatal Nursery at Mahatma Ghandi Hospital. Final report

Where do the germs live in your environment? April 2010 Shelly Padgett, BSN, RN Nurse Educator, 7N, Central Monitoring, and Cardiac Access Center

How to safely collect blood samples from persons suspected to be infected with highly infectious blood-borne pathogens (e.g.

BMI Werndale Hospital Quality Accounts April 2013 to March 2014

adult services between 1 January and 31 December 2013 had an operation where the

Cholera / Response / 1. Response to an Epidemic of Cholera

RELEVANT HACCP CHARTS: Preparation, Service

Prevention of healthcare associated (nosocomial) infection : Safer surgery overview of strategies

Original Article:

VRE. Living with. Learning how to control the spread of Vancomycin-resistant enterococci (VRE)

Open and Honest Care in your Local Hospital

A Safe Patient. Commonwealth Nurses Federation. Jill ILIFFE Executive Secretary. Commonwealth Nurses Federation

CMS Manual System Pub State Operations Provider Certification

Peninsula Community Health. Safe Use of Mattresses, Pressure Relieving Cushions and Pillows

Control of Clostridium difficile Infection (CDI) Outbreaks in Hospitals. A Guide for Hospital and Health Unit Staff

MRSA Positive. An information guide

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection

Transcription:

Clostridium difficile Sub-Committee Health Protection Surveillance Centre Sample Root Cause Analysis Tool of Hospital-acquired Clostridium difficile Infection Version 3, January 2016 This document has been adapted from the root cause analysis tool developed by the infection prevention and control team, Connolly Hospital, Dublin. We gratefully acknowledge their permission to use their document. Hospital teams may wish to adapt this tool accordingly. We welcome feedback and comments on this tool at info@hpsc.ie 1

Name of person coordinating this root cause analysis: Name(s) & position(s) of person(s) performing this root cause analysis: Date: Copy of this report sent to (circle all relevant): Consultant caring for patient with CDI Ward Manager CEO/Hospital Manager Director of Nursing Risk manager Clinical director Other (please state) 1. Demographics Patient name: Medical record number: Date of birth: Ward: Consultant: Date of admission: Admitted from: (please circle) Ward and dates where patient was in this hospital prior to CDI diagnosis Home Other hospital (name) Nursing home (name) Other healthcare facility (name) Ward Date 2

2. C. difficile infection (CDI) Has this episode of CDI been acquired in this hospital? Yes No Case type (please circle) Is this patient part of an outbreak/cluster of CDI? C. difficile ribotype (if available) Does the patient have risk factors for CDI (please circle all risk factors) Outcome (please circle) New case of CDI Recurrent CDI (state number of recurrences) Unknown Yes give details: No Age >65 years Previous hospital admissions Recent antibiotic use (previous 12 weeks) Recently on ward/unit with other CDI cases Proton Pump Inhibitors Laxative use Immunosuppression Inflammatory bowel disease Other underlying disease NG feeding GI surgery Other Symptoms resolved Still symptomatic Death if so was CDI a contributory factor? 3. Antibiotic history in previous 12 weeks Antibiotic (Name, route) Date commenced Date complete Indication Compliance with hospital policy (yes/no) 3

If antibiotics were not prescribed in accordance with hospital guidelines give details: 4

4. Management of the patient with CDI - Infection Prevention and Control Date of onset of diarrhoea: Date and time specimen sent to the laboratory for C. difficile toxin testing: Date and time of positive C. difficile results: Date and time of isolation in single room? Time to isolation in a single room from onset of symptoms: Time to isolation in a single room from confirmation of CDI: Was the patient isolated in a single room with en suite facilities and a clinical hand basin? If there was no single rooms available: 1. Has a risk assessment been performed to ensure there are no available options for single room placement? 2. Was the patient cohort nursed, with en suite facilities or individual commode? Are staff aware that hand WASHING with soap (antimicrobial or non antimicrobial) and water must be used for all hand decontamination when caring for patients with CDI (as per WHO 5 Moments for Hand Hygiene) Is personal protective equipment (PPE), i.e., disposable gloves and plastic aprons readily available to staff when entering the cohort area or isolation room? Have all commodes and toilets been cleaned with detergent and then disinfected with 1000ppm available chlorine? Has a cleaning regimen of the cohort/isolation area and all equipment in the area (detergent and 1000ppm available chlorine) been established in line with hospital policy? Is the bedpan washer in the ward working, has it been serviced appropriately & service records visible? 5

Has patient care equipment been dedicated for the specific use of patients with CDI, e.g. blood pressure cuffs, stethoscopes and thermometers Has the patient been shown how to perform hand hygiene? If the patient cannot perform hand hygiene has assistance been provided by ward staff? Has the clinical microbiologist been contacted to request C. difficile typing in the case of a) severe disease, b) suspected outbreak? 5. Clinical management of the patient with CDI Has the patient been informed that they have CDI? Is this documented in the medical notes Has the patient been given a CDI information leaflet? Does the patient have an up to date stool chart (e.g., Bristol Stool Chart)? Has their medication been reviewed by their medical team: specifically a review of antibiotic, proton pump inhibitor and laxative therapy and unnecessary agents stopped? (please circle) Are there daily clinical assessments recorded in the medical notes to assess for signs of severe CDI? Antibiotics reviewed: Yes No - N/A PPI reviewed: Yes No - N/A Laxatives reviewed Yes No - N/A Is the patient on appropriate CDI specific antimicrobial therapy in accordance with hospital guidelines Date anti CDI therapy commenced: 6

Is specific anti-cdi therapy in line with national guidelines? Yes No if no, why not Does the patient have severe CDI? If so was a surgical opinion requested? Did the patient require: 1. ICU admission 2. Surgery for megacolon/colitis 6. Recent audit results if available for this and other wards where the patient is suspected of acquiring CDI Date Ward area Audit Result Comment Hand hygiene Environmental hygiene Sluice room audit Mattress checks Antibiotic consumption Antibiotic audit 7. Learning Lessons and Changing Systems - What could have contributed to this episode of CDI? 1. Were any deficiencies in antibiotic prescribing identified that could have contributed to patient susceptibility? If yes, list the systems changed to rectify this and reduce the risk of recurrence? 2. Were there any deficiencies in practice that could have contributed to cross-transmission or delayed detection? e.g., Delayed or non-isolation Delayed sending of specimens Inadequate contact precautions use of PPE Use of alcohol based hand rub rather than antiseptic soap & water Excess patient movement If yes, list the systems changed to rectify this and reduce the risk of recurrence? 7

3. Were any deficiencies in the maintenance of a safe patient environment identified? e.g. Cluttered environment Inadequately cleaned environment Inadequately cleaned equipment, commodes, washbowls Insufficient single-rooms to isolate all patients requiring contact precautions? 4. Were there any other factors that could have contributed to the CDI identified? If yes, list the systems changed to rectify this and reduce the risk of recurrence? If yes, list the systems changed to rectify this and reduce the risk of recurrence? 5. What other preventive measures could be instigated? 8